Jazz Pharmaceuticals plc — Director's Dealing 2024

May 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-05-03

Reporting Person: Patil Neena M (EVP & Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-03	Ordinary Shares	S	5000	$109.65	Disposed	36629	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $109.58 to $109.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.